- WGO COVID19 and Liver Disease
- WGO guidance for patients with COVID 19 and liver disease
- Therapies under investigation for COVID 19 and potential hepatotoxicity
- Performing procedures in chronic liver disease patients
- Metabolic dysfunction associated fatty liver disease and COVID 19
- Management of HCC during COVID 19
- Management of autoimmune liver disease during COVID-19
- Liver transplantation and COVID19 what will change
- How to follow up patients with chronic liver disease during COVID 19
- COVID 19